Request for Information on Toxicological and Physicochemical Data of Engineered Nanomaterials To Evaluate in Developing Categorical Occupational Exposure Limits (OELs), 68935-68936 [2019-27169]
Download as PDF
Federal Register / Vol. 84, No. 242 / Tuesday, December 17, 2019 / Notices
and Conservation, William R.
Snodgrass—Tennessee Tower, 11th
Floor, 312 Rosa L. Parks Avenue,
Nashville, Tennessee 37243; and the
Drinking Water Section, U.S.
Environmental Protection Agency,
Region 4, 61 Forsyth Street SW, Atlanta,
Georgia 30303.
FOR FURTHER INFORMATION CONTACT: Dale
Froneberger, EPA Region 4, Drinking
Water Section, by mail at the Atlanta
street address given above, by telephone
at (404) 562–9446, or by email at
froneberger.dale@epa.gov.
SUPPLEMENTARY INFORMATION: The State
of Tennessee has submitted a request
that EPA approve a revision to the
State’s Safe Drinking Water Act Public
Water System Supervision Program to
include the authority to implement and
enforce the Revised Total Coliform Rule.
For the request to be approved, EPA
must find the state regulations codified
at Tenn. Comp. R. & Regs. 0400–45–01
to be no less stringent than the federal
rule codified at 40 CFR part 141. EPA
reviewed Tennessee’s application using
the federal statutory provisions (Section
1413 of the Safe Drinking Water Act),
federal regulations (at 40 CFR parts 141
and 142), state regulations, state policies
and procedures for implementing the
rule, regulatory crosswalk, and EPA
regulatory guidance to determine
whether the request for revision is
approvable. EPA determined that the
Tennessee regulations are no less
stringent than the corresponding federal
rule and the revision otherwise meets
applicable Safe Drinking Water Act
requirements. Therefore, EPA intends to
approve this revision. If EPA does not
receive a timely and appropriate request
for a hearing and the Regional
Administrator does not elect to hold a
hearing on her own motion, this
approval shall become final and
effective on January 16, 2020.
of the FDIC Building located at 550 17th
Street NW, Washington, DC.
STATUS: Closed.
MATTERS TO BE CONSIDERED: In calling
the meeting, the Board determined, on
motion of Director Joseph M. Otting
(Comptroller of the Currency), seconded
by Director Martin J. Gruenberg, and
concurred in by Director Kathleen L.
Kraninger (Director, Consumer
Financial Protection Bureau), and
Chairman Jelena McWilliams, that
Corporation business required its
consideration of the matters which were
to be the subject of this meeting on less
than seven days’ notice to the public;
that no earlier notice of the meeting was
practicable; that the public interest did
not require consideration of the matters
in a meeting open to public observation;
and that the matters could be
considered in a closed meeting by
authority of subsections (c)(4), (c)(6),
(c)(8), (c)(9)(A)(ii), and (c)(9)(B) of the
‘‘Government in the Sunshine Act’’ (5
U.S.C. 552b(c)(4), (c)(6), (c)(8),
(c)(9)(A)(ii), and (c)(9)(B).
CONTACT PERSON FOR MORE INFORMATION:
Requests for further information
concerning the meeting may be directed
to Mr. Robert E. Feldman, Executive
Secretary of the Corporation, at 202–
898–7043.
Authority: Section 1413 of the Safe
Drinking Water Act, as amended (1996), and
40 CFR part 142.
[CDC–2019–0111, NIOSH–332]
Dated: December 2, 2019.
Mary S. Walker,
Regional Administrator, Region 4.
[FR Doc. 2019–27156 Filed 12–16–19; 8:45 am]
jbell on DSKJLSW7X2PROD with NOTICES
BILLING CODE 6714–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Request for Information on
Toxicological and Physicochemical
Data of Engineered Nanomaterials To
Evaluate in Developing Categorical
Occupational Exposure Limits (OELs)
National Institute for
Occupational Safety and Health
(NIOSH) of the Centers for Disease
Control and Prevention (CDC),
Department of Health and Human
Services (HHS).
ACTION: Request for information.
FEDERAL DEPOSIT INSURANCE
CORPORATION
Sunshine Act Meeting
3:49 p.m. on Thursday,
December 12, 2019.
PLACE: The meeting was held in the
Board Room located on the sixth floor
TIME AND DATE:
18:15 Dec 16, 2019
[FR Doc. 2019–27218 Filed 12–13–19; 11:15 am]
AGENCY:
BILLING CODE 6560–50–P
VerDate Sep<11>2014
Dated at Washington, DC, on, December 12,
2019.
Federal Deposit Insurance Corporation.
Robert E. Feldman,
Executive Secretary.
Jkt 250001
The National Institute for
Occupational Safety and Health
(NIOSH) of the Centers for Disease
Control and Prevention (CDC) intends to
SUMMARY:
PO 00000
Frm 00061
Fmt 4703
Sfmt 4703
68935
evaluate the scientific data on
engineered nanomaterials (ENMs) to
develop categorical occupational
exposure limits (OELs) based on the
available scientific evidence regarding
the hazard or safety of these materials.
NIOSH seeks to obtain materials,
including published and unpublished
reports and research findings, to
evaluate the possible adverse health
risks of occupational exposure to ENMs.
DATES: Electronic or written comments
must be received by February 18, 2020.
ADDRESSES: You may submit comments,
identified by CDC–2019–0111 and
Docket Number NIOSH–332, by either
of the two following methods:
• Federal eRulemaking Portal:
https://www.regulations.gov. Follow the
instructions for submitting comments.
• Mail: NIOSH Docket Office, Robert
A. Taft Laboratories, MS–C34, 1090
Tusculum Avenue, Cincinnati, OH
45226.
Instructions: All information received
in response to this notice must include
the agency name and docket number
[CDC–2019–0111; NIOSH–332]. All
relevant comments received will be
posted without change to https://
www.regulations.gov, including any
personal information provided. All
electronic comments should be
formatted in Microsoft Word. Please
make reference to CDC–2019–0111 and
Docket Number NIOSH–332.
FOR FURTHER INFORMATION CONTACT:
Nathan M. Drew, MS, NIOSH, MS–C14,
1090 Tusculum Avenue, Cincinnati, OH
45226, telephone (513) 533–8352.
SUPPLEMENTARY INFORMATION: In 2017,
NIOSH contributed to the International
Organization for Standardization (ISO)
technical report on frameworks for
developing OELs for nano-objects [ISO
2016]. In 2019, NIOSH published a
Technical Report on occupational
exposure banding guidance [NIOSH
2019]. The information presented in
these Technical Reports represents the
most recent update of the scientific
rationale and methodology for
establishing hazard values for
chemicals, which includes ENMs.
The development of an OEL for an
individual chemical involves a critical
review of the available scientific data in
humans and animals to identify relevant
studies and to characterize the various
lines of evidence that can support the
derivation of the OEL. NIOSH requests
information for ENMs to include
human, animal, and cellular toxicology
data, including but not limited to:
Acute, subchronic, or chronic data; the
physicochemical characterization of
those ENMs; and other information
about the biological mechanisms and
E:\FR\FM\17DEN1.SGM
17DEN1
68936
Federal Register / Vol. 84, No. 242 / Tuesday, December 17, 2019 / Notices
toxicological effects of ENMs. NIOSH is
also seeking information on studies that
include evaluating the dose-response
relationships between exposure to
ENMs and the development of adverse
lung effects including inflammation,
fibrosis, or neoplasia. Supporting
information for published studies
should include a full citation. For
unpublished studies please include
authors, affiliations, year, and any
context on how the data were collected.
NIOSH will publish a Technical
Report which describes the data,
methods, and findings for the
development of categorical OELs for
ENMs, which may include relevant
information submitted in response to
this request. The draft Technical Report
will be made available for public
comment in a subsequent notice.
References
[ISO 2016] Nanotechnologies—Overview of
available frameworks for the
development of occupational exposure
limits and bands for nano-objects and
their aggregates and agglomerates
(NOAAs). International Organization for
Standardization (ISO) Technical Report.
ISO/TR 18637, published November 21.
ISO, Geneva, Switzerland.
[NIOSH 2019] Technical report: The NIOSH
occupational exposure banding process
for chemical risk management. By Lentz
TJ, Seaton M, Rane P, Gilbert SJ,
McKernan LT, Whittaker C. Cincinnati,
OH: U.S. Department of Health and
Human Services, Centers for Disease
Control and Prevention, National
Institute for Occupational Safety and
Health, DHHS (NIOSH) Publication No.
2019–132
John J. Howard,
Director, National Institute for Occupational
Safety and Health, Centers for Disease Control
and Prevention.
[FR Doc. 2019–27169 Filed 12–16–19; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Medicare & Medicaid
Services
[Document Identifiers: CMS–10638, CMS–
R–5, CMS–287–19, and CMS–10088]
Agency Information Collection
Activities: Submission for OMB
Review; Comment Request
Centers for Medicare &
Medicaid Services, HHS.
ACTION: Notice.
jbell on DSKJLSW7X2PROD with NOTICES
AGENCY:
The Centers for Medicare &
Medicaid Services (CMS) is announcing
an opportunity for the public to
comment on CMS’ intention to collect
SUMMARY:
VerDate Sep<11>2014
18:15 Dec 16, 2019
Jkt 250001
information from the public. Under the
Paperwork Reduction Act of 1995
(PRA), federal agencies are required to
publish notice in the Federal Register
concerning each proposed collection of
information, including each proposed
extension or reinstatement of an existing
collection of information, and to allow
a second opportunity for public
comment on the notice. Interested
persons are invited to send comments
regarding the burden estimate or any
other aspect of this collection of
information, including the necessity and
utility of the proposed information
collection for the proper performance of
the agency’s functions, the accuracy of
the estimated burden, ways to enhance
the quality, utility, and clarity of the
information to be collected, and the use
of automated collection techniques or
other forms of information technology to
minimize the information collection
burden.
DATES: Comments on the collection(s) of
information must be received by the
OMB desk officer by January 16, 2020.
ADDRESSES: When commenting on the
proposed information collections,
please reference the document identifier
or OMB control number. To be assured
consideration, comments and
recommendations must be received by
the OMB desk officer via one of the
following transmissions: OMB, Office of
Information and Regulatory Affairs,
Attention: CMS Desk Officer, Fax
Number: (202) 395–5806 OR Email:
OIRA_submission@omb.eop.gov.
To obtain copies of a supporting
statement and any related forms for the
proposed collection(s) summarized in
this notice, you may make your request
using one of following:
1. Access CMS’ website address at
website address at https://www.cms.gov/
Regulations-and-Guidance/Legislation/
PaperworkReductionActof1995/PRAListing.html.
1. Email your request, including your
address, phone number, OMB number,
and CMS document identifier, to
Paperwork@cms.hhs.gov.
2. Call the Reports Clearance Office at
(410) 786–1326.
FOR FURTHER INFORMATION CONTACT:
William Parham at (410) 786–4669.
SUPPLEMENTARY INFORMATION: Under the
Paperwork Reduction Act of 1995 (PRA)
(44 U.S.C. 3501–3520), federal agencies
must obtain approval from the Office of
Management and Budget (OMB) for each
collection of information they conduct
or sponsor. The term ‘‘collection of
information’’ is defined in 44 U.S.C.
3502(3) and 5 CFR 1320.3(c) and
includes agency requests or
requirements that members of the public
PO 00000
Frm 00062
Fmt 4703
Sfmt 4703
submit reports, keep records, or provide
information to a third party. Section
3506(c)(2)(A) of the PRA (44 U.S.C.
3506(c)(2)(A)) requires federal agencies
to publish a 30-day notice in the
Federal Register concerning each
proposed collection of information,
including each proposed extension or
reinstatement of an existing collection
of information, before submitting the
collection to OMB for approval. To
comply with this requirement, CMS is
publishing this notice that summarizes
the following proposed collection(s) of
information for public comment:
1. Type of Information Collection
Request: Revision with change of a
currently approved collection; Title of
Information Collection: Application for
New Medical Services and Technologies
Seeking to Qualify for Add-On
Payments Under the Hospital Inpatient
Prospective Payment System; Use:
Section 1886(d)(5)(K) authorizes the
Secretary to establish a special payment
methodology for new medical services
and technologies used in inpatient
procedures. To qualify for additional
payments under this provision; a new
technology must represent a substantial
clinical improvement; data reflecting
the cost of new technology must not yet
be available in the data used to
recalibrate the Medicare severity
diagnosis-related groups (MS–DRGs);
and the MS–DRG payment rate
otherwise applicable to the new
technology would be inadequate (see 42
CFR 412.87(b)). we are revising the
estimated annual number of
respondents from 32 to 62, based on the
proposed alternative new technology
add-on payment pathway for certain
devices included in the FY 2020 IPPS
proposed rule (CMS–1716–P). The
existing regulations at 42 CFR 412.87
implement these provisions and specify
three criteria for a new medical service
or technology to receive the additional
payment: (1) The medical service or
technology must be new; (2) the medical
service or technology must be costly
such that the DRG rate otherwise
applicable to discharges involving the
medical service or technology is
determined to be inadequate; and (3) the
service or technology must demonstrate
a substantial clinical improvement over
existing services or technologies.
In the FY 2020 IPPS proposed rule (84
FR 19371—19373), we proposed an
alternative new technology add-on
payment pathway for certain devices.
Specifically, for applications received
for new technology add-on payments for
FY 2021 and subsequent fiscal years, we
proposed that a medical device that has
received Federal Drug Administration
(FDA) marketing authorization (that is,
E:\FR\FM\17DEN1.SGM
17DEN1
Agencies
[Federal Register Volume 84, Number 242 (Tuesday, December 17, 2019)]
[Notices]
[Pages 68935-68936]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2019-27169]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[CDC-2019-0111, NIOSH-332]
Request for Information on Toxicological and Physicochemical Data
of Engineered Nanomaterials To Evaluate in Developing Categorical
Occupational Exposure Limits (OELs)
AGENCY: National Institute for Occupational Safety and Health (NIOSH)
of the Centers for Disease Control and Prevention (CDC), Department of
Health and Human Services (HHS).
ACTION: Request for information.
-----------------------------------------------------------------------
SUMMARY: The National Institute for Occupational Safety and Health
(NIOSH) of the Centers for Disease Control and Prevention (CDC) intends
to evaluate the scientific data on engineered nanomaterials (ENMs) to
develop categorical occupational exposure limits (OELs) based on the
available scientific evidence regarding the hazard or safety of these
materials.
NIOSH seeks to obtain materials, including published and
unpublished reports and research findings, to evaluate the possible
adverse health risks of occupational exposure to ENMs.
DATES: Electronic or written comments must be received by February 18,
2020.
ADDRESSES: You may submit comments, identified by CDC-2019-0111 and
Docket Number NIOSH-332, by either of the two following methods:
Federal eRulemaking Portal: https://www.regulations.gov.
Follow the instructions for submitting comments.
Mail: NIOSH Docket Office, Robert A. Taft Laboratories,
MS-C34, 1090 Tusculum Avenue, Cincinnati, OH 45226.
Instructions: All information received in response to this notice
must include the agency name and docket number [CDC-2019-0111; NIOSH-
332]. All relevant comments received will be posted without change to
https://www.regulations.gov, including any personal information
provided. All electronic comments should be formatted in Microsoft
Word. Please make reference to CDC-2019-0111 and Docket Number NIOSH-
332.
FOR FURTHER INFORMATION CONTACT: Nathan M. Drew, MS, NIOSH, MS-C14,
1090 Tusculum Avenue, Cincinnati, OH 45226, telephone (513) 533-8352.
SUPPLEMENTARY INFORMATION: In 2017, NIOSH contributed to the
International Organization for Standardization (ISO) technical report
on frameworks for developing OELs for nano-objects [ISO 2016]. In 2019,
NIOSH published a Technical Report on occupational exposure banding
guidance [NIOSH 2019]. The information presented in these Technical
Reports represents the most recent update of the scientific rationale
and methodology for establishing hazard values for chemicals, which
includes ENMs.
The development of an OEL for an individual chemical involves a
critical review of the available scientific data in humans and animals
to identify relevant studies and to characterize the various lines of
evidence that can support the derivation of the OEL. NIOSH requests
information for ENMs to include human, animal, and cellular toxicology
data, including but not limited to: Acute, subchronic, or chronic data;
the physicochemical characterization of those ENMs; and other
information about the biological mechanisms and
[[Page 68936]]
toxicological effects of ENMs. NIOSH is also seeking information on
studies that include evaluating the dose-response relationships between
exposure to ENMs and the development of adverse lung effects including
inflammation, fibrosis, or neoplasia. Supporting information for
published studies should include a full citation. For unpublished
studies please include authors, affiliations, year, and any context on
how the data were collected.
NIOSH will publish a Technical Report which describes the data,
methods, and findings for the development of categorical OELs for ENMs,
which may include relevant information submitted in response to this
request. The draft Technical Report will be made available for public
comment in a subsequent notice.
References
[ISO 2016] Nanotechnologies--Overview of available frameworks for
the development of occupational exposure limits and bands for nano-
objects and their aggregates and agglomerates (NOAAs). International
Organization for Standardization (ISO) Technical Report. ISO/TR
18637, published November 21. ISO, Geneva, Switzerland.
[NIOSH 2019] Technical report: The NIOSH occupational exposure
banding process for chemical risk management. By Lentz TJ, Seaton M,
Rane P, Gilbert SJ, McKernan LT, Whittaker C. Cincinnati, OH: U.S.
Department of Health and Human Services, Centers for Disease Control
and Prevention, National Institute for Occupational Safety and
Health, DHHS (NIOSH) Publication No. 2019-132
John J. Howard,
Director, National Institute for Occupational Safety and Health,
Centers for Disease Control and Prevention.
[FR Doc. 2019-27169 Filed 12-16-19; 8:45 am]
BILLING CODE 4163-18-P